Novelion Therapeutics - Daily Chart

Name
*Data as of: 2017-08-15
Company Summary DEVELOPS OCULAR PRODUCTS USED TO TREAT CERTAIN INHERITED RET INAL DISEASES.
Daily Stock Data   Dates and Ratios   Company Background
Symbol NVLN Earnings Date 2017-11-01 Exchange NASDAQ
Name Novelion Therapeutics Ex Dividend Date N/A Sector Medical
Close $7.67 Exp. Dividend Amount N/A Industry Medical - Biomed / Biotech
$ Change
-0.10
Dividend Yield 0.00 Market Cap 143M
% Change
-1.30%
Alpha 0.05 Enterprise Value 293M
Open 7.63 Beta 0.39 Shares 1000s 18,603
Days Range 7.44 - 7.69 Daily ATR 0.32 Incorp Date 1981
52 Week Range 6.85 - 13.80 Daily ATR% 4.17% IPO Date
Volume 6,200 Price/Earnings 0.00 Location Vancouver,BC
Avg Vol 50d 41,050 Price/Book 1.05 ADR No
Vol % Chg vs 50 Day
-24.10%
Price/Sales 1.69 Options Yes
Up/Down Volume 1.30 PEG 0.00 ETF/Closed End Fund No
AD Rating Timeliness Rating Industry Group Rank
Symbol Comp Rating EPS Rating SMR Rating RS Rating Sponsor Rating Current Last Week Current Last Week Ind Group RS Current Last Week 3 Months Ago 6 Months Ago Industry Group Sector
NVLN 38 60 E 16 B D- D- C C A+ 6 7 32 40 Medical-Biomed/Biotech MEDICAL
   
Stock Symbol   Sector   Industry Group
NVLN   Medical   Medical - Biomed / Biotech
Overall Stock Ratings   Stock Ratings within Sector   Stock Ratings within Industry
Full 42.77 Full 47.0133 Full 52.39
Earnings 53.60 Earnings 74.21 Earnings 87.24
Sales 33.21 Sales 27.70 Sales 24.83
Margins 15.00 Margins 37.61 Margins 46.47
Valuation 2.66 Valuation 1.02 Valuation 0.68
Best Rated Stocks Overall   Best Rated Stocks in Sector:
Medical
  Best Rated Stocks in Industry:
Medical - Biomed / Biotech
ESNT 100.00 CORT 100.00 CORT 100.00
JP 99.96 LMAT 99.87 BIVV 99.77
YY 99.96 FONR 99.75 SUPN 99.32
FB 99.94 ABMD 99.62 CELG 99.32
ANET 99.92 HSKA 99.49 REGN 99.09
*All ratings range from 0 to 100 with 100 being the highest.
 
Stock Symbol   Sector   Industry Group
NVLN   Medical   Medical - Biomed / Biotech
% Gain   Average Stock Gain % in Sector   Average Stock Gain % in Industry
1 Day
-1.30%
1 Day
+0.06%
1 Day
-0.24%
1 Week
+0.00%
1 Week
-0.01%
1 Week
-1.61%
2 Weeks
+0.00%
2 Weeks
-0.68%
2 Weeks
-1.38%
3 Weeks
+0.00%
3 Weeks
-1.82%
3 Weeks
-3.87%
1 Month
+0.00%
1 Month
-1.24%
1 Month
-0.76%
3 Months
+0.00%
3 Months
+4.29%
3 Months
+10.21%
6 Months
+0.00%
6 Months
+13.48%
6 Months
+18.00%
1 year
+0.00%
1 year
+11.78%
1 year
+19.19%
YTD
+0.00%
YTD
+18.98%
YTD
+30.45%
 
Sector Info   Sector Ranking   Average Stock Gain % in Sector
Symbol NVLN Current 15 1 Day
+0.06%
Sector Medical Yesterday 15 1 Week
-0.01%
Market Val(Bil) 4,139.35B 1 Week Ago 18 2 Weeks
-0.68%
Industry Groups 361 2 Week Ago 10 3 Week
-1.82%
Total Stocks 636 3 Week Ago 10 1 Month
-1.24%
New Highs 10 1 Month Ago 14 3 Month
+4.29%
New Highs % 1.57% 3 Month Ago 20 6 Months
+13.48%
New Lows 27 6 Month Ago 29 1 year
+11.78%
New Lows % 4.25% 1 Year Ago 21 YTD
+18.98%
 
Industry Group Info   Industry Group Ranking   Average Stock Gain % in Industry
Symbol NVLN Current 36 1 Day
-0.24%
Industry Group Medical - Biomed / Biotech Yesterday 27 1 Week
-1.61%
Market Val(Bil) 751.95B 1 Week Ago 33 2 Weeks
-1.38%
Total Stocks 361 2 Weeks Ago 21 3 Weeks
-3.87%
New Highs 2 3 Weeks Ago 14 1 Month
-0.76%
New Highs % 0.55% 1 Month Ago 40 3 Months
+10.21%
New Lows 13 3 Months Ago 126 6 Months
+18.00%
New Lows % 3.60% 6 Months Ago 124 1 Year
+19.19%
      1 Year Ago 121 YTD
+30.45%
Data as of: 2017-08-15
Daily Stock Data   Dates and Ratios   Company Background
Symbol NVLN Earnings Date 2017-11-01 Exchange NASDAQ
Name Novelion Therapeutics Ex Dividend Date N/A Sector MEDICAL
Close 7.67 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change -0.1 Dividend Yield 0 Market_Cap_mil 142.5
% Change -1.3 Alpha 0.05 Enterprise_Val_mil 292.9
Open 7.63 Beta 0.39 Shares_1000s 18603
Day's Range 7.44 - 7.69 Daily ATR 0.32 Incorp_Date 1981
52 Week Range 6.85 - 13.8 Daily ATR% 4.17 IPO Date
Volume 620,000 Price/Earnings Location Vancouver,BC
Avg Vol 50d 4,105,000 Price/Book 1.05 ADR No
Short Volume 1,078,572 Price/Sales 1.69 Options Yes
Shrt Int Pcnt Chg -37.1 PEG ETF/Closed End Fund No
Data as of: 2017-08-15
Daily Stock Data   Dates and Ratios   Company Background
Symbol NVLN Earnings Date 2017-11-01 Exchange NASDAQ
Name Novelion Therapeutics Ex Dividend Date N/A Sector MEDICAL
Close 7.67 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change -0.1 Dividend Yield 0 Market_Cap_mil 142.5
% Change -1.3 Alpha 0.05 Enterprise_Val_mil 292.9
Open 7.63 Beta 0.39 Shares_1000s 18603
Day's Range 7.44 - 7.69 Daily ATR 0.32 Incorp_Date 1981
52 Week Range 6.85 - 13.8 Daily ATR% 4.17 IPO Date
Volume 620,000 Price/Earnings Location Vancouver,BC
Avg Vol 50d 4,105,000 Price/Book 1.05 ADR No
Short Volume 1,078,572 Price/Sales 1.69 Options Yes
Shrt Int Pcnt Chg -37.1 PEG ETF/Closed End Fund No
Sales Ratings (0 to 10) Sales Accelerating % Sales Growth % Sales Growth Rank
Symbol Overall within Sector within Industry Annual Sales 2Q 3Q Last Qtr Last Yr 3 Years 5 Years Last Qtr Last Yr 3 Years 5 Years
NVLN 33.21 27.7 24.83 13.6M No No
Data as of: 2017-08-15
Daily Stock Data   Dates and Ratios   Company Background
Symbol NVLN Earnings Date 2017-11-01 Exchange NASDAQ
Name Novelion Therapeutics Ex Dividend Date N/A Sector MEDICAL
Close 7.67 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change -0.1 Dividend Yield 0 Market_Cap_mil 142.5
% Change -1.3 Alpha 0.05 Enterprise_Val_mil 292.9
Open 7.63 Beta 0.39 Shares_1000s 18603
Day's Range 7.44 - 7.69 Daily ATR 0.32 Incorp_Date 1981
52 Week Range 6.85 - 13.8 Daily ATR% 4.17 IPO Date
Volume 620,000 Price/Earnings Location Vancouver,BC
Avg Vol 50d 4,105,000 Price/Book 1.05 ADR No
Short Volume 1,078,572 Price/Sales 1.69 Options Yes
Shrt Int Pcnt Chg -37.1 PEG ETF/Closed End Fund No
Margins Ratings (0 to 10) Average After Tax Margins
Symbol Overall within Sector within Industry Pretax Margin Last Qtr After Tax Margin Accel 3Q After Tax Margin Last Qtr 2 Qtr 3 Qtr 4 Qtr 5 Qtr 6 Qtr
NVLN 15 37.61 46.47 -969.9 No
 
Stock Symbol   Sector   Industry Group
NVLN   Medical   Medical - Biomed / Biotech
Ratios   Average Ratios in Sector   Average Ratios in Industry
Price/Earnings (PE) 0.00 Price/Earnings (PE) 90.56 Price/Earnings (PE) 106.00
Price/Book (PB) 1.05 Price/Book (PB) 0.80 Price/Book (PB) 1.73
Price/Sales (PS) 1.69 Price/Sales (PS) 220.26 Price/Sales (PS) 417.39
Price/Cash Flow (PCF) -4.15 Price/Cash Flow (PCF) 0.35 Price/Cash Flow (PCF) -9.71
PEG 0.00 PEG 2.12 PEG 0.68
Dividend Adj PEG 0.00 Dividend Adj PEG 1.82 Dividend Adj PEG 0.67
Return on Equity (ROE) -95.50 Return on Equity (ROE) -92.79 Return on Equity (ROE) -116.29
Yield 0.00 Yield 0.23 Yield 0.02
Current Ratio 1.42 Current Ratio 5.65 Current Ratio 7.45
Debt % 166.10% Debt % 92.78% Debt % 47.26%
Long Term Debt/Work Capital 5.24 Long Term Debt/Work Capital -0.75 Long Term Debt/Work Capital 0.21
 
Stock NVLN   Exponential Moving Averages   Simple Moving Averages
Name Novelion Therapeutics EMA 10 days
7.74(-0.9%)
SMA 10 days
7.72(-0.65%)
Close $7.67 EMA 20 days
7.75(-1.03%)
SMA 20 days
7.72(-0.65%)
$ Change
-0.10
EMA 50 days
7.76(-1.16%)
SMA 50 days
7.72(-0.65%)
% Change
-1.30%
EMA 89 days
7.76(-1.16%)
SMA 79 days
7.72(-0.65%)
Volume 6,200 EMA 100 days
7.76(-1.16%)
SMA 100 days
7.72(-0.65%)
Avg Volume 41,050 EMA 200 days
7.76(-1.16%)
SMA 200 days
7.72(-0.65%)
Vol% vs. Avg Vol
-24.10%
           
Up/Down Vol 1.30   Keltner Channel   Bollinger Band
Distribution Days 0   Upper
8.17(-6.12%)
  Upper
0.00(0%)
ATR 0.32   Mid
7.75(-1.03%)
  Mid
7.72(-0.65%)
ATR% 4.17%   Lower
7.33(4.64%)
  Lower
0.00(0%)